Initial Experience with Sutureless Sorin Perceval S Aortic Prosthesis for the Treatment of Prosthetic Valve Endocarditis

Abstract

Background The objective of this study is to evaluate results of the initial experience with sutureless Perceval S for active prosthetic valve endocarditis (PVE).

Materials and Methods From October 2012 to April 2014, five patients underwent surgery for aortic PVE with Perceval S bioprosthesis.

Results There was one in-hospital death (20%). Echocardiography performed at discharge showed excellent hemodynamic performance of Perceval S bioprosthesis.

Conclusion Aortic valve replacement with Perceval S sutureless valve in patients with PVE is a feasible and safe procedure, associated with low in-hospital mortality and good hemodynamic performance of the prosthesis.

Keywords

endocarditis - valve replacement - sutureless

• References

• 1 Bonow RO, Carabello BA, Chatterjee K , et al; 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118 (15) e523-e661
• 2 Habib G, Hoen B, Tornos P , et al; ESC Committee for Practice Guidelines; Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009; 30 (19) 2369-2413
• 3 Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis 2008; 50 (4) 274-281
• 4 Delay D, Pellerin M, Carrier M , et al. Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis. Ann Thorac Surg 2000; 70 (4) 1219-1223
• 5 Anguera I, Miro JM, San Roman JA , et al; Aorto-Cavitary Fistula in Endocarditis Working Group. Periannular complications in infective endocarditis involving prosthetic aortic valves. Am J Cardiol 2006; 98 (9) 1261-1268
• 6 Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002; 74 (3) 650-659 , discussion 659
• 7 Yankah AC, Pasic M, Klose H, Siniawski H, Weng Y, Hetzer R. Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg 2005; 28 (1) 69-75
• 8 Avierinos JF, Thuny F, Chalvignac V , et al. Surgical treatment of active aortic endocarditis: homografts are not the cornerstone of outcome. Ann Thorac Surg 2007; 84 (6) 1935-1942
• 9 Miceli A, Croccia M, Simeoni S , et al. Root replacement with stentless Freestyle bioprostheses for active endocarditis: a single centre experience. Interact Cardiovasc Thorac Surg 2013; 16 (1) 27-30
• 10 Miceli A, Santarpino G, Pfeiffer S , et al. Minimally invasive aortic valve replacement with Perceval S sutureless valve: early outcomes and one-year survival from two European centers. J Thorac Cardiovasc Surg 2014; 148 (6) 2838-2843